liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Recombinant amyloid beta-peptide production by coexpression with an affibody ligand.
Department of Medical Biochemistry, University of Gothenburg.
Department of Medical Biochemistry, University of Gothenburg.
Department of Medical Biochemistry, University of Gothenburg.
Department of Chemistry, University of Cambridge.
Show others and affiliations
2008 (English)In: BMC biotechnology, ISSN 1472-6750, Vol. 8, 82- p.Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Oligomeric and fibrillar aggregates of the amyloid beta-peptide (Abeta) have been implicated in the pathogenesis of Alzheimer's disease (AD). The characterization of Abeta assemblies is essential for the elucidation of the mechanisms of Abeta neurotoxicity, but requires large quantities of pure peptide. Here we describe a novel approach to the recombinant production of Abeta. The method is based on the coexpression of the affibody protein ZAbeta3, a selected affinity ligand derived from the Z domain three-helix bundle scaffold. ZAbeta3 binds to the amyloidogenic central and C-terminal part of Abeta with nanomolar affinity and consequently inhibits aggregation. RESULTS: Coexpression of ZAbeta3 affords the overexpression of both major Abeta isoforms, Abeta(1-40) and Abeta(1-42), yielding 4 or 3 mg, respectively, of pure 15N-labeled peptide per liter of culture. The method does not rely on a protein-fusion or -tag and thus does not require a cleavage reaction. The purified peptides were characterized by NMR, circular dichroism, SDS-PAGE and size exclusion chromatography, and their aggregation propensities were assessed by thioflavin T fluorescence and electron microscopy. The data coincide with those reported previously for monomeric, largely unstructured Abeta. ZAbeta3 coexpression moreover permits the recombinant production of Abeta(1-42) carrying the Arctic (E22G) mutation, which causes early onset familial AD. Abeta(1-42)E22G is obtained in predominantly monomeric form and suitable, e.g., for NMR studies. CONCLUSION: The coexpression of an engineered aggregation-inhibiting binding protein offers a novel route to the recombinant production of amyloidogenic Abeta peptides that can be advantageously employed to study the molecular basis of AD. The presented expression system is the first for which expression and purification of the aggregation-prone Arctic variant (E22G) of Abeta(1-42) is reported.

Place, publisher, year, edition, pages
2008. Vol. 8, 82- p.
National Category
Natural Sciences
URN: urn:nbn:se:liu:diva-45430DOI: 10.1186/1472-6750-8-82ISI: 000262160300001PubMedID: 18973685OAI: diva2:266292
Original Publication: Bertil Macao, Wolfgang Hoyer, Anders Sandberg, Ann-Christin Brorsson, Christopher M Dobson and Torleif Härd, Recombinant amyloid beta-peptide production by coexpression with an affibody ligand., 2008, BMC biotechnology, (8), 82. Licensee: BioMed Central Available from: 2009-10-10 Created: 2009-10-10 Last updated: 2010-09-24

Open Access in DiVA

fulltext(1854 kB)316 downloads
File information
File name FULLTEXT01.pdfFile size 1854 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Brorsson, Ann-Christin
Natural Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 316 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 68 hits
ReferencesLink to record
Permanent link

Direct link